Efficacy and Safety of LBH589B in Adult Patients With Refractory Chronic Myeloid Leukemia in Accelerated or Blast Phase

Roswell Park Cancer Institute, Buffalo

University of Rochester Medical Center, Rochester

Wake Forest University Health Sciences, Winston-Salem

Duke University Hospital, Durham

Emory University School of Medicine-Winship Cancer Institute, Nashville

Vanderbilt University Medical Center, Clinical Trials Center, Nashville

Indiana Blood and Marrow Institute/St. Francis Hospital, Beech Grove

University of Michigan, Ann Arbor

Mayo Clinic Cancer Center, Rochester

Northwestern University Clinical Research Office, Chicago

Rush University Medical Center, Chicago

University Chicago Hospital, Chicago

University of Texas Southwestern Medical Center, Dallas

University of Colorado Health Sciences Center/Anschutz Cancer Pavilion, Aurora

Rocky Mountain Cancer Center, Denver

City of Hope National Medical Center, Duarte

Oregon Health & Science University, Portland

Seattle Cancer Care Alliance, Seattle

Hackensack University Medical Center/Oncology Research Dept., Hackensack

Novartis Investigative Site, Cologne

Novartis Investigative Site, Düsseldorf

Novartis Investigative Site, Hamburg

Novartis Investigative Site, Leipzig

Novartis Investigative Site, Mainz

Novartis Investigative Site, Mannheim

Novartis Investigative Site, Munich